Dr. Kenneth Mugwanya is an Assistant Professor and core faculty member in the Department of Global Health. His research interests aim to develop, evaluate, and implement interventions likely to have the greatest impact to prevent new HIV infections. Recently, Mugwanya and several co-authors conducted a study investigating the feasibility of providing antiretroviral drugs at family clinics. The study took place in Kenya, where Mugwanya is a director of two large PrEP studies.

Read the entire story at EurekAlert, a related story on ContagionLive, and a journal article featuring other DGH faculty members at PLOS Medicine.